{
"info": {
"nct_id": "NCT02413320",
"official_title": "Randomized Open Label Phase II Trial of Neoadjuvant Carboplatin Plus Docetaxel or Carboplatin Plus Paclitaxel Followed by Doxorubicin Plus Cyclophosphamide in Stage I-III Triple-negative Breast Cancer",
"inclusion_criteria": "* Patients with newly diagnosed stage I (T>1cm), II or III triple negative breast cancer who have not had definitive breast surgery or received systemic chemotherapy\n* The invasive tumor must be hormone receptor-poor, defined as both estrogen receptor and progesterone receptor staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry.\n* HER- 2 negativity will be based on the current ASCO-CAP guidelines for HER testing\n* No prior chemotherapy, endocrine therapy or radiation therapy with therapeutic intent for this cancer\n* Female subjects age 18 - 70 years\n* ECOG Performance Status of 0-1\n* Adequate organ and marrow function as defined below:\n\n * Leukocytes ≥ 3,000/uL\n * Absolute neutrophil count ≥ 1500/uL\n * Platelets ≥ 100,000/uL\n * Total bilirubin ≤ 1.5mg/dL\n * AST(SGOT)/ALT(SPGT) ≤ 2 x institutional upper limit of normal\n * Creatinine ≤ 1.5mg/dl and/or Creatinine Clearance ≥ 60mL/min\n * Serum albumin ≥ 3.0 g/dL\n* Women of child-bearing potential must agree to use adequate contraception\n* Pretreatment lab values must be performed within 14 days of treatment initiation, and other baseline studies performed within 30 days prior to registration\n* Subjects should have LVEF ≥ 50% by echocardiogram or MUGA scan performed within 4 weeks prior to treatment initiation\n* Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound within 4 weeks prior to treatment initiation\n* Subjects with clinically/radiologically abnormal axillary lymph nodes should have pathological confirmation of disease with image guided biopsy/fine needle aspiration.\n* Subjects must be already enrolled in P.R.O.G.E.C.T observational registry\n* Staging to rule out metastatic disease is recommended for subjects with clinical stage III disease\n* Subjects with bilateral disease are eligible if they meet other eligibility criteria.\n* Neuropathy: No baseline neuropathy grade > 2\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* Current or anticipated use of other investigational agents\n* Subject has received chemotherapy, radiotherapy or surgery for the treatment of breast cancer\n* Subject with metastatic disease\n* History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study\n* Subjects with inflammatory breast cancer\n* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection or psychiatric illness/social situations that would limit compliance with study requirements\n* Subject is pregnant or nursing\n* Subjects with concomitant or previous malignancies within the last 5 years. Exceptions include: adequately treated basal or squamous cell carcinoma of the skin, carcinoma in situ of the cervix, and ductal carcinoma in situ (DCIS).\n* Ejection Fraction <50% on ECHO or MUGA\n* Cardiac function: Subjects with congestive heart failure, myocardial infarction, unstable angina pectoris, an arterial thrombotic event, stroke or transient ischemia attack within the past 12 months, uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90), uncontrolled or symptomatic arrhythmia, or grade ≥ 2 peripheral vascular disease",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* HER- 2 negativity will be based on the current ASCO-CAP guidelines for HER testing",
"criterions": [
{
"exact_snippets": "HER- 2 negativity",
"criterion": "HER-2 status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "HER- 2 negativity",
"criterion": "HER-2 status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
}
]
}
},
{
"identified_line": {
"line": "* No prior chemotherapy, endocrine therapy or radiation therapy with therapeutic intent for this cancer",
"criterions": [
{
"exact_snippets": "No prior chemotherapy",
"criterion": "prior chemotherapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No prior ... endocrine therapy",
"criterion": "prior endocrine therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No prior ... radiation therapy with therapeutic intent",
"criterion": "prior radiation therapy with therapeutic intent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No prior chemotherapy",
"criterion": "prior chemotherapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No prior ... endocrine therapy",
"criterion": "prior endocrine therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No prior ... radiation therapy with therapeutic intent",
"criterion": "prior radiation therapy with therapeutic intent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Female subjects age 18 - 70 years",
"criterions": [
{
"exact_snippets": "Female subjects",
"criterion": "gender",
"requirement": {
"requirement_type": "value",
"expected_value": "female"
}
},
{
"exact_snippets": "age 18 - 70 years",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 70,
"unit": "years"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Female subjects",
"criterion": "gender",
"requirement": {
"requirement_type": "value",
"expected_value": "female"
}
},
{
"exact_snippets": "age 18 - 70 years",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 70,
"unit": "years"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* ECOG Performance Status of 0-1",
"criterions": [
{
"exact_snippets": "ECOG Performance Status of 0-1",
"criterion": "ECOG Performance Status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG Performance Status of 0-1",
"criterion": "ECOG Performance Status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Adequate organ and marrow function as defined below:",
"criterions": [
{
"exact_snippets": "Adequate organ and marrow function",
"criterion": "organ and marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Adequate organ and marrow function",
"criterion": "organ and marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Leukocytes ≥ 3,000/uL",
"criterions": [
{
"exact_snippets": "Leukocytes ≥ 3,000/uL",
"criterion": "leukocytes",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "uL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Leukocytes ≥ 3,000/uL",
"criterion": "leukocytes",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "uL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Absolute neutrophil count ≥ 1500/uL",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1500/uL",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "uL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1500/uL",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "uL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Platelets ≥ 100,000/uL",
"criterions": [
{
"exact_snippets": "Platelets ≥ 100,000/uL",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "uL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Platelets ≥ 100,000/uL",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "uL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Total bilirubin ≤ 1.5mg/dL",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤ 1.5mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Total bilirubin ≤ 1.5mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* AST(SGOT)/ALT(SPGT) ≤ 2 x institutional upper limit of normal",
"criterions": [
{
"exact_snippets": "AST(SGOT)/ALT(SPGT) ≤ 2 x institutional upper limit of normal",
"criterion": "AST(SGOT)/ALT(SPGT) levels",
"requirement": {
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x institutional upper limit of normal"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "AST(SGOT)/ALT(SPGT) ≤ 2 x institutional upper limit of normal",
"criterion": "AST(SGOT)/ALT(SPGT) levels",
"requirement": {
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x institutional upper limit of normal"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Serum albumin ≥ 3.0 g/dL",
"criterions": [
{
"exact_snippets": "Serum albumin ≥ 3.0 g/dL",
"criterion": "serum albumin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 3.0,
"unit": "g/dL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Serum albumin ≥ 3.0 g/dL",
"criterion": "serum albumin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 3.0,
"unit": "g/dL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Women of child-bearing potential must agree to use adequate contraception",
"criterions": [
{
"exact_snippets": "Women of child-bearing potential",
"criterion": "child-bearing potential",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "must agree to use adequate contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "agreement",
"expected_value": true
}
},
{
"exact_snippets": "must agree to use adequate contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Women of child-bearing potential",
"criterion": "child-bearing potential",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"then_criteria": {
"and_criteria": [
{
"exact_snippets": "must agree to use adequate contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "agreement",
"expected_value": true
}
},
{
"exact_snippets": "must agree to use adequate contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Pretreatment lab values must be performed within 14 days of treatment initiation, and other baseline studies performed within 30 days prior to registration",
"criterions": [
{
"exact_snippets": "Pretreatment lab values must be performed within 14 days of treatment initiation",
"criterion": "pretreatment lab values",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
},
{
"exact_snippets": "other baseline studies performed within 30 days prior to registration",
"criterion": "baseline studies",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Pretreatment lab values must be performed within 14 days of treatment initiation",
"criterion": "pretreatment lab values",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
},
{
"exact_snippets": "other baseline studies performed within 30 days prior to registration",
"criterion": "baseline studies",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound within 4 weeks prior to treatment initiation",
"criterions": [
{
"exact_snippets": "Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound",
"criterion": "breast and axillary imaging",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "within 4 weeks prior to treatment initiation",
"criterion": "timing of imaging",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound",
"criterion": "breast and axillary imaging",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"or_criteria": [
{
"exact_snippets": "Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound",
"criterion": "breast MRI",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Subjects should have breast and axillary imaging with breast MRI or breast and axillary ultrasound",
"criterion": "breast and axillary ultrasound",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
},
{
"exact_snippets": "within 4 weeks prior to treatment initiation",
"criterion": "timing of imaging",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Subjects with clinically/radiologically abnormal axillary lymph nodes should have pathological confirmation of disease with image guided biopsy/fine needle aspiration.",
"criterions": [
{
"exact_snippets": "clinically/radiologically abnormal axillary lymph nodes",
"criterion": "axillary lymph nodes",
"requirement": {
"requirement_type": "abnormality",
"expected_value": true
}
},
{
"exact_snippets": "pathological confirmation of disease",
"criterion": "disease confirmation",
"requirement": {
"requirement_type": "method",
"expected_value": [
"image guided biopsy",
"fine needle aspiration"
]
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "clinically/radiologically abnormal axillary lymph nodes",
"criterion": "axillary lymph nodes",
"requirement": {
"requirement_type": "abnormality",
"expected_value": true
}
},
"then_criteria": {
"exact_snippets": "pathological confirmation of disease",
"criterion": "disease confirmation",
"requirement": {
"requirement_type": "method",
"expected_value": [
"image guided biopsy",
"fine needle aspiration"
]
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Subjects must be already enrolled in P.R.O.G.E.C.T observational registry",
"criterions": [
{
"exact_snippets": "Subjects must be already enrolled in P.R.O.G.E.C.T observational registry",
"criterion": "enrollment in P.R.O.G.E.C.T observational registry",
"requirement": {
"requirement_type": "enrollment status",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Subjects must be already enrolled in P.R.O.G.E.C.T observational registry",
"criterion": "enrollment in P.R.O.G.E.C.T observational registry",
"requirement": {
"requirement_type": "enrollment status",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Staging to rule out metastatic disease is recommended for subjects with clinical stage III disease",
"criterions": [
{
"exact_snippets": "clinical stage III disease",
"criterion": "clinical stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "III"
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "clinical stage III disease",
"criterion": "clinical stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "III"
}
},
"then_criteria": null,
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Subjects with bilateral disease are eligible if they meet other eligibility criteria.",
"criterions": [
{
"exact_snippets": "bilateral disease",
"criterion": "bilateral disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "bilateral disease",
"criterion": "bilateral disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "if they meet other eligibility criteria",
"criterion": "other eligibility criteria",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Neuropathy: No baseline neuropathy grade > 2",
"criterions": [
{
"exact_snippets": "Neuropathy: No baseline neuropathy grade > 2",
"criterion": "neuropathy",
"requirement": {
"requirement_type": "grade",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Neuropathy: No baseline neuropathy grade > 2",
"criterion": "neuropathy",
"requirement": {
"requirement_type": "grade",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Current or anticipated use of other investigational agents",
"criterions": [
{
"exact_snippets": "Current or anticipated use of other investigational agents",
"criterion": "use of investigational agents",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Current or anticipated use of other investigational agents",
"criterion": "use of investigational agents",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Subject has received chemotherapy, radiotherapy or surgery for the treatment of breast cancer",
"criterions": [
{
"exact_snippets": "Subject has received chemotherapy ... for the treatment of breast cancer",
"criterion": "chemotherapy for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Subject has received ... radiotherapy ... for the treatment of breast cancer",
"criterion": "radiotherapy for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Subject has received ... surgery for the treatment of breast cancer",
"criterion": "surgery for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Subject has received chemotherapy ... for the treatment of breast cancer",
"criterion": "chemotherapy for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Subject has received ... radiotherapy ... for the treatment of breast cancer",
"criterion": "radiotherapy for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Subject has received ... surgery for the treatment of breast cancer",
"criterion": "surgery for breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Subject with metastatic disease",
"criterions": [
{
"exact_snippets": "metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "metastatic disease",
"criterion": "metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study",
"criterions": [
{
"exact_snippets": "History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study",
"criterion": "allergic reactions",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study",
"criterion": "allergic reactions",
"requirement": {
"requirement_type": "compounds",
"expected_value": [
"carboplatin",
"docetaxel",
"doxorubicin",
"cyclophosphamide",
"paclitaxel",
"other agents used in the study"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study",
"criterion": "allergic reactions",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of allergic reactions to compounds of similar chemical or biologic composition to carboplatin, docetaxel, doxorubicin, cyclophosphamide, paclitaxel, or other agents used in the study",
"criterion": "allergic reactions",
"requirement": {
"requirement_type": "compounds",
"expected_value": [
"carboplatin",
"docetaxel",
"doxorubicin",
"cyclophosphamide",
"paclitaxel",
"other agents used in the study"
]
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Subjects with inflammatory breast cancer",
"criterions": [
{
"exact_snippets": "inflammatory breast cancer",
"criterion": "inflammatory breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "inflammatory breast cancer",
"criterion": "inflammatory breast cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection or psychiatric illness/social situations that would limit compliance with study requirements",
"criterions": [
{
"exact_snippets": "Uncontrolled intercurrent illness",
"criterion": "intercurrent illness",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "ongoing or active infection",
"criterion": "infection",
"requirement": {
"requirement_type": "status",
"expected_value": [
"ongoing",
"active"
]
}
},
{
"exact_snippets": "psychiatric illness",
"criterion": "psychiatric illness",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "social situations that would limit compliance with study requirements",
"criterion": "social situations",
"requirement": {
"requirement_type": "impact on compliance",
"expected_value": "limit"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Uncontrolled intercurrent illness",
"criterion": "intercurrent illness",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
},
{
"or_criteria": [
{
"exact_snippets": "ongoing or active infection",
"criterion": "infection",
"requirement": {
"requirement_type": "status",
"expected_value": [
"ongoing",
"active"
]
}
},
{
"exact_snippets": "psychiatric illness",
"criterion": "psychiatric illness",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "social situations that would limit compliance with study requirements",
"criterion": "social situations",
"requirement": {
"requirement_type": "impact on compliance",
"expected_value": "limit"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Subjects with concomitant or previous malignancies within the last 5 years. Exceptions include: adequately treated basal or squamous cell carcinoma of the skin, carcinoma in situ of the cervix, and ductal carcinoma in situ (DCIS).",
"criterions": [
{
"exact_snippets": "concomitant or previous malignancies within the last 5 years",
"criterion": "malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
},
{
"exact_snippets": "adequately treated basal or squamous cell carcinoma of the skin",
"criterion": "basal or squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
},
{
"exact_snippets": "carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "ductal carcinoma in situ (DCIS)",
"criterion": "ductal carcinoma in situ (DCIS)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "adequately treated basal or squamous cell carcinoma of the skin",
"criterion": "basal or squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
},
{
"exact_snippets": "carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "ductal carcinoma in situ (DCIS)",
"criterion": "ductal carcinoma in situ (DCIS)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"exact_snippets": "concomitant or previous malignancies within the last 5 years",
"criterion": "malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Ejection Fraction <50% on ECHO or MUGA",
"criterions": [
{
"exact_snippets": "Ejection Fraction <50%",
"criterion": "ejection fraction",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "%"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Ejection Fraction <50%",
"criterion": "ejection fraction",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "%"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Cardiac function: Subjects with congestive heart failure, myocardial infarction, unstable angina pectoris, an arterial thrombotic event, stroke or transient ischemia attack within the past 12 months, uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90), uncontrolled or symptomatic arrhythmia, or grade ≥ 2 peripheral vascular disease",
"criterions": [
{
"exact_snippets": "congestive heart failure",
"criterion": "congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "an arterial thrombotic event",
"criterion": "arterial thrombotic event",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "stroke",
"criterion": "stroke",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "transient ischemia attack",
"criterion": "transient ischemic attack",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90)",
"criterion": "uncontrolled hypertension",
"requirement": {
"requirement_type": "systolic blood pressure",
"expected_value": {
"operator": ">",
"value": 160,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90)",
"criterion": "uncontrolled hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 90,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "uncontrolled or symptomatic arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled or symptomatic arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
},
{
"exact_snippets": "grade ≥ 2 peripheral vascular disease",
"criterion": "peripheral vascular disease",
"requirement": {
"requirement_type": "grade",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90)",
"criterion": "uncontrolled hypertension",
"requirement": {
"requirement_type": "systolic blood pressure",
"expected_value": {
"operator": ">",
"value": 160,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "uncontrolled hypertension (Systolic BP>160 or Diastolic BP>90)",
"criterion": "uncontrolled hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 90,
"unit": "mmHg"
}
}
}
]
},
{
"exact_snippets": "uncontrolled or symptomatic arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled or symptomatic arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
}
]
},
{
"exact_snippets": "congestive heart failure",
"criterion": "congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "myocardial infarction",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "an arterial thrombotic event",
"criterion": "arterial thrombotic event",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "stroke",
"criterion": "stroke",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "transient ischemia attack",
"criterion": "transient ischemic attack",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "grade ≥ 2 peripheral vascular disease",
"criterion": "peripheral vascular disease",
"requirement": {
"requirement_type": "grade",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "N/A"
}
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Patients with newly diagnosed stage I (T>1cm), II or III triple negative breast cancer who have not had definitive breast surgery or received systemic chemotherapy",
"criterions": [
{
"exact_snippets": "newly diagnosed stage I (T>1cm), II or III triple negative breast cancer",
"criterion": "breast cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"I",
"II",
"III"
]
}
},
{
"exact_snippets": "newly diagnosed stage I (T>1cm), II or III triple negative breast cancer",
"criterion": "tumor size",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "cm"
}
}
},
{
"exact_snippets": "triple negative breast cancer",
"criterion": "breast cancer type",
"requirement": {
"requirement_type": "type",
"expected_value": "triple negative"
}
},
{
"exact_snippets": "who have not had definitive breast surgery",
"criterion": "definitive breast surgery",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "or received systemic chemotherapy",
"criterion": "systemic chemotherapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "newly diagnosed stage I (T>1cm), II or III triple negative breast cancer",
"criterion": "breast cancer stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"I",
"II",
"III"
]
}
},
{
"exact_snippets": "newly diagnosed stage I (T>1cm), II or III triple negative breast cancer",
"criterion": "tumor size",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "cm"
}
}
}
]
},
{
"exact_snippets": "triple negative breast cancer",
"criterion": "breast cancer type",
"requirement": {
"requirement_type": "type",
"expected_value": "triple negative"
}
}
]
},
{
"not_criteria": {
"exact_snippets": "who have not had definitive breast surgery",
"criterion": "definitive breast surgery",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
]
},
{
"not_criteria": {
"exact_snippets": "or received systemic chemotherapy",
"criterion": "systemic chemotherapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
]
}
},
{
"identified_line": {
"line": "* The invasive tumor must be hormone receptor-poor, defined as both estrogen receptor and progesterone receptor staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry.",
"criterions": [
{
"exact_snippets": "invasive tumor must be hormone receptor-poor",
"criterion": "hormone receptor status",
"requirement": {
"requirement_type": "status",
"expected_value": "poor"
}
},
{
"exact_snippets": "estrogen receptor ... staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry",
"criterion": "estrogen receptor staining",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "% of invasive cancer cells"
}
}
},
{
"exact_snippets": "progesterone receptor staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry",
"criterion": "progesterone receptor staining",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "% of invasive cancer cells"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "estrogen receptor ... staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry",
"criterion": "estrogen receptor staining",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "% of invasive cancer cells"
}
}
},
{
"exact_snippets": "progesterone receptor staining present in ≤ 10% of invasive cancer cells by Immunohistochemistry",
"criterion": "progesterone receptor staining",
"requirement": {
"requirement_type": "percentage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "% of invasive cancer cells"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Creatinine ≤ 1.5mg/dl and/or Creatinine Clearance ≥ 60mL/min",
"criterions": [
{
"exact_snippets": "Creatinine ≤ 1.5mg/dl",
"criterion": "creatinine level",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dl"
}
}
},
{
"exact_snippets": "Creatinine Clearance ≥ 60mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Creatinine \u0010 1.5mg/dl",
"criterion": "creatinine level",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dl"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Creatinine Clearance \u0010 60mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Subjects should have LVEF ≥ 50% by echocardiogram or MUGA scan performed within 4 weeks prior to treatment initiation",
"criterions": [
{
"exact_snippets": "LVEF ≥ 50% by echocardiogram or MUGA scan",
"criterion": "LVEF",
"requirement": {
"requirement_type": "measurement",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "echocardiogram or MUGA scan performed within 4 weeks prior to treatment initiation",
"criterion": "echocardiogram or MUGA scan timing",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 4 weeks prior to treatment initiation"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "LVEF \u001e 50% by echocardiogram or MUGA scan",
"criterion": "LVEF",
"requirement": {
"requirement_type": "measurement",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "echocardiogram or MUGA scan performed within 4 weeks prior to treatment initiation",
"criterion": "echocardiogram or MUGA scan timing",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 4 weeks prior to treatment initiation"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "LVEF \u001e 50% by echocardiogram or MUGA scan",
"criterion": "LVEF",
"requirement": {
"requirement_type": "measurement",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "echocardiogram or MUGA scan performed within 4 weeks prior to treatment initiation",
"criterion": "echocardiogram or MUGA scan timing",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 4 weeks prior to treatment initiation"
}
}
]
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Subject is pregnant or nursing",
"criterions": [
{
"exact_snippets": "Subject is pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Subject is pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
}
],
"failed_miscellaneous": []
}